Moreover, the established HCC markers [40], AFP (11.4- and 12.3-fold higher in the tumors of control and chemerin-156 infected mice, respectively) and glypican-3 (17.3- and 21.4-fold higher in the tumors of control and chemerin-156 infected mice, respectively) were markedly increased in tumorous versus non-tumorous tissues for both groups (Table S1). The gene discussed is RARRES2; the disease is hepatocellular carcinoma.